Tag: vascular resistance

1. Treatment with sotatercept decreased pulmonary vascular resistance in patients with pulmonary arterial hypertension. 2. Sotatercept caused adverse side effects of thrombocytopenia and increased hemoglobin level. Evidence Rating Level: 1 (Excellent)    Study Rundown: Pulmonary arterial hypertension (PAH) is driven by reduced bone morphogenic protein receptor type 2 (BMP2) and increased activin signaling...